Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Kyndel Gyn AB
AB
Active
Org 5591817605
Svartmangatan 7
Medical specialists activities · NACE 8622
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 180K
+300% vs 2023
EBITDA margin
96.1%
+424% vs 2023
Equity ratio
74.4%
Financial strength
Net profit 2024
SEK 138K
+393% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2020
0M
0%
2021
1M
+100%
2022
0M
-100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 180K
+300%
EBITDA
SEK 173K
+424%
Net profit
SEK 138K
+393%
Total assets
SEK 313K
-35%
Equity
SEK 233K
-32%
Employees
0
—
Company information
Legal name
Kyndel Gyn AB
Org number
5591817605
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
26 november 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva specialistläkarverksamhet inom gynekologi och obstetrik samt därmed förenlig verksamhet.
Contact
Address
Svartmangatan 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
115
87
572
45
180
Staff expenses
—
—
—
—
—
EBITDA
112
82
564
33
173
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
112
82
564
33
173
Net financials
—
—
—
2
1
Profit before tax
112
82
564
35
174
Tax
−24
−17
−117
−7
−36
Net profit
88
65
447
28
138
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
311
274
760
480
313
Equity
259
235
502
345
233
Long-term debt
0
0
0
0
0
Short-term debt
53
38
258
134
80
Total debt
53
38
258
134
80
Financial ratios
5-year trend
EBITDA margin
96.1%
This company
15.8%
Market median
+508% vs market
2020
2024
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
2020
2024
Return on equity
59.2%
This company
18.4%
Market median
+222% vs market
2020
2024
Net profit margin
76.7%
This company
8.1%
Market median
+847% vs market
2020
2024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
2020
2024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AK
Anna Kyndel
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
GT
Göran Torsten Andreas Hedefalk
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Kyndel Gyn AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Kyndel
Chief Executive Officer
0 companies
Göran Torsten Andreas Hedefalk
Deputy Board Member
0 companies